Lv1
36 积分 2022-10-05 加入
Emerging Insights in Lipoprotein(a) and Novel Lipid Therapies
1天前
求助中
Ulcerative Colitis in Adults
2个月前
已完结
Current status and future perspectives of FGF21 analogues in clinical trials
2个月前
已完结
Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments
2个月前
已完结
Guselkumab in the IL-23 inhibition landscape for ulcerative colitis
2个月前
已完结
What Is Ulcerative Colitis?
2个月前
已完结
Safety and efficacy of GLP-1/FGF21 dual agonist HEC88473 in MASLD and T2DM: a randomized, double-blind, placebo-controlled study
2个月前
已完结
Fibroblast growth factor receptor 1/Klothoβ agonist BFKB8488A improves lipids and liver health markers in patients with diabetes or NAFLD: A phase 1b randomized trial
2个月前
已完结
Insights into the results of Resmetirom trials: Can a thyroid hormone receptor agonist be the holy grail of MASH therapy?
2个月前
已完结
Metabolic dysfunction-associated steatotic liver disease in adults
2个月前
已完结
皖公网安备34019202002308
